PAVBLU
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PAVBLU, covering 2024-08-23 to 2026-04-14. Get the full timeline:
Most recent: EMA Authorised: Pavblu (aflibercept) — Amgen Technology (Ireland) UC
2 regulatory and trial events tracked for PAVBLU, covering 2024-08-23 to 2026-04-14. Get the full timeline:
Most recent: EMA Authorised: Pavblu (aflibercept) — Amgen Technology (Ireland) UC